Prodromal Symptoms clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
open to eligible people ages 13-25
The present study is a confirmatory efficacy trial of Family Focused Therapy for youth at clinical high risk for psychosis (FFT-CHR). This trial is sponsored by seven mature CHR clinical research programs from the North American Prodrome Longitudinal Study (NAPLS). The young clinical high risk sample (N = 220 youth ages 13-25) is to be followed at 6-month intervals for 18 months.
at UCLA UCSD UCSF
Our lead scientists for Prodromal Symptoms research studies include Kristin S. Cadenhead, M.D. Carrie E. Bearden, Ph.D. Daniel H. Mathalon, Ph.D., M.D. David J. Miklowitz, Ph.D. Holly K. Hamilton, Ph.D..